MMIS, Inc. is a leading SaaS-based enterprise global compliance software company to the pharmaceutical and medical device industry internationally. The Company’s product suite is comprised of high value-added business collaboration and compliance software modules which create a unique end-to-end solution.

The Company’s compliance solutions are in high demand from clients due to the current requirements for pharmaceutical and medical device companies to comply with “open payments” regulations under The Sunshine Act in the U.S. and similar regulations globally. MMIS, Inc. pursued an equity financing to further accelerate its growth and capitalize on the favorable market environment for its services.

With the assistance of Cypress, MMIS, Inc. successfully structured and executed a private placement of Series A-1 Convertible Preferred Stock purchased by EDG Partners Fund II, L.P.

Cypress acted as the exclusive placement agent to MMIS, Inc. in connection with the Company’s growth equity recapitalization transaction.

In the course of the transaction, Cypress also provided value-add financial advisory expertise, including negotiating the valuation used to determine EDG’s pro forma equity ownership in the recapitalized company and developing the strategy to redeem all outstanding shares from owners of the Company’s previously outstanding preferred stock.